Share This Blog
- Luncheon with the Experts in New York City -- Carcinoid and Neuroendocrine Tumor Patients Are Invited!
- Carcinoid and Neuroendocrine Tumor Specialist Dr. Eugene A. Woltering Named Chair of AJCC Expert Panel
- A Possible Cure for Neuroendocrine Cancer: Exciting Update!
- But You Look So Good . . . Stories by Carcinoid Cancer Survivors
- 14 Inspirational Carcinoid and Neuroendocrine Tumor Survivor Stories
- @a_swisstory sent you an email to connect with others in the #carcinoid #NETCancer community. Hope you got it! 3 days ago
- Do #doctors need guidance treating #NeuroendocrineCancer patients? Great online resource for physicians: bit.ly/1sNdaPg 4 days ago
- Recognizing great #cancer advocates on #FF: @teaminspire, @jangeissler, @myHEARTyrHANDS, @PLANETSCHARITY, @RareDiseases, @DominicNutt. 4 days ago
- @CarcinoidStory, we've learned more about how you connect with/create a group in Switzerland. Can you contact us via our website? 1 week ago
- Dr. Eugene Woltering named Chair of @AJCCancer Expert Panel on #NeuroendocrineTumors. bit.ly/1hXy0Xv http://t.co/aYBuQ52P27 1 week ago
Tag Archives: Gallium-68 Octreotide PET scan
RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients
Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund. According to Ebrahim S. … Continue reading